Gilead Sciences (GILD) Cash from Investing Activities (2009 - 2026)

Gilead Sciences (GILD) has 18 years of Cash from Investing Activities data on file, last reported at $1.8 billion in Q1 2026.

• Quarterly Cash from Investing Activities rose 526.51% year-over-year to $1.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.6 billion (down 57.39% YoY) and the FY2025 annual result came in at -$4.8 billion, down 38.97% from the prior year.
• Cash from Investing Activities grew to $1.8 billion in Q1 2026, from -$1.8 billion in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $1.8 billion in Q1 2026 to a low of -$2.2 billion in Q1 2024.
• A 5-year average of -$659.0 million and a median of -$483.0 million in 2023 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2025 — Cash from Investing Activities slumped 715.56% — and 2026, when it surged 526.51%.
• Tracing GILD's Cash from Investing Activities over 5 years: stood at -$375.0 million in 2022, then tumbled by 93.87% to -$727.0 million in 2023, then soared by 69.05% to -$225.0 million in 2024, then tumbled by 715.56% to -$1.8 billion in 2025, then jumped by 196.46% to $1.8 billion in 2026.
• The last three Cash from Investing Activities figures came in at $1.8 billion (Q1 2026), -$1.8 billion (Q4 2025), and -$427.0 million (Q3 2025), per Business Quant data.